A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: Experiences from 13 phase I studies

European Journal of Pharmaceutical Sciences - Tập 30 - Trang 432-440 - 2007
Lars Nyberg1, Wiking Månsson1, Bertil Abrahamsson2, Janeric Seidegård3, Olof Borgå1
1Bioperm AB, Dalbyvägen 23, SE-224 60 Lund, Sweden
2AstraZeneca R&D Mölndal, SE-431 83 Mölndal, Sweden
3Discovery Medicine, AstraZeneca R&D Lund, SE-221 87 Lund, Sweden

Tài liệu tham khảo

Adkin, 1995, The effects of pharmaceutical excipients on small intestinal transit, Br. J. Clin. Pharmacol., 39, 381, 10.1111/j.1365-2125.1995.tb04466.x Barr, 1994, Differential absorption of amoxicillin from the human small and large intestine, Clin. Pharmacol. Ther., 56, 279, 10.1038/clpt.1994.138 Benet, 1996, Intestinal drug metabolism and anti-transport processes: a potential paradigm shift in oral drug delivery, J. Control. Release, 39, 139, 10.1016/0168-3659(95)00147-6 Bonlokke, 1997, A new approach for direct in vivo dissolution studies of poorly soluble drugs, Pharm. Res., 14, 1490, 10.1023/A:1012149511768 Chan, 1994, Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers, Pharm. Res., 11, 432, 10.1023/A:1018925407109 Clear, 2001, Evaluation of the InteliSite capsule to deliver theophylline and frusemide tablets to the small intestine and colon, Eur. J. Pharm. Sci., 13, 375, 10.1016/S0928-0987(01)00134-8 Fagerholm, 1997, Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms, J. Pharm. Pharmacol., 49, 687, 10.1111/j.2042-7158.1997.tb06093.x Gramatté, 1994, Site-dependent small intestinal absorption of ranitidine, Eur. J. Clin. Pharmacol., 46, 253, 10.1007/BF00192558 Harder, 1990, Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule, Br. J. Clin. Pharmacol., 30, 35, 10.1111/j.1365-2125.1990.tb03740.x Jönsson, 1995, Budesonide is metabolized by cytochrome P450 (CYP3A) in human liver, Drug Metab. Dispos., 23, 137 Kararli, 1995, Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals, Biopharm. Drug Dispos., 16, 351, 10.1002/bdd.2510160502 Lambert, 1991, Autonomous telemetric capsule to explore the small bowel, Med. Biol. Eng. Comput., 29, 191, 10.1007/BF02447107 Lennernäs, 1992, Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man, Pharm. Res., 9, 1243, 10.1023/A:1015888813741 Lown, 1997, Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine, Clin. Pharmacol. Ther., 62, 248, 10.1016/S0009-9236(97)90027-8 Paine, 1997, Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism, J. Pharmacol. Exp. Ther., 283, 1552 Petri, 2006, Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers, Int. J. Clin. Pharmacol. Ther., 44, 71, 10.5414/CPP44071 Pithavala, 1998, Use of the InteliSite capsule to study ranitidine absorption from various sites within the human intestinal tract, Pharm. Res., 15, 1869, 10.1023/A:1011910223812 1975 Staib, 1986, Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device, Eur. J. Clin. Pharmacol., 30, 691, 10.1007/BF00608217 Ungell, 1998, Membrane transport of drugs in different regions of the intestinal tract of the rat, J. Pharm. Sci., 87, 360, 10.1021/js970218s Wilding, 2000, Development of a new engineering-based capsule for human drug absorption studies, Pharm. Sci. Technol. Today, 3, 385, 10.1016/S1461-5347(00)00311-4 Wu, 1995, Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine, Clin. Pharmacol. Ther., 59, 492, 10.1016/0009-9236(95)90168-X